TUESDAY, Feb. 15 (HealthDay News) -- Coffee drinkers may have reason to smile: Daily coffee consumption seems to reduce the risk of liver cancer, a new study finds.
And drinking decaffeinated coffee seems to cut colorectal cancer risk, another study claims.
Both papers appear in the Feb. 16 issue of the Journal of the National Cancer Institute.
"We were surprised. We didn't expect the decaf findings," said Karin B. Michels, an associate professor of epidemiology at Harvard Medical School, and lead author of the study that looked at caffeine consumption and colorectal cancer risk.
And drinking decaffeinated coffee seems to cut colorectal cancer risk, another study claims.
Both papers appear in the Feb. 16 issue of the Journal of the National Cancer Institute.
"We were surprised. We didn't expect the decaf findings," said Karin B. Michels, an associate professor of epidemiology at Harvard Medical School, and lead author of the study that looked at caffeine consumption and colorectal cancer risk.
Comments